Our Innovation
The novel combination of two graft types—bone allograft, which is utilized and recognized in many types of procedures, and amniotic/chorionic fetal layers, or scaffold and several native growth factors—leads to a significant reduction in inflammation.
We are undertaking, for the first time, tissue transplantation without immunological rejection, with actual low inflammation and no medical medicines, and the highest strength. The outcome is excellent regeneration.
CHAMBOGRAFT
Only superior scientists can predict the brilliant combination of the Chorionic layer, Amniotic layer, bone allograft, and its novel effects.
Latest Insights in
Regenerative Medicine
Why Chambograft is Different?
Bone Growth
Promotes osteoinduction and osteoconduction for rapid bone regeneration.
Low Rejection
Decellularized membranes reduce immune response and enhance acceptance.
Fast Healing
Minimizes inflammation and accelerates tissue recovery—naturally.
Surgical Control
Improved graft strength and handling during surgical procedures.
The Market Behind the Innovation
The global amniotic membrane market is rapidly growing, driven by demand for regenerative medicine. North America alone accounts for 31.5% of global revenue as of 2023. With a projected CAGR of 13.1% from 2024 to 2030, the market is expected to surpass $3.2 billion, powered by applications in orthopedics, wound healing, and surgical grafts. At Chambograft, we are pioneering this momentum—combining science, clinical success, and opportunity.
Global Market Size (2022)
CAGR (2024–2030)
North America Share (2023)
Usage in Ortho & Wound Care